Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2017

Novel Invasive Diagnostics II: NIRS-Based

Presenter: Ik-Kyung Jang, Yoshinobu Onuma, David Erlinge

November 01, 2017

Presentation TCT 2017

Prospects for Hypothermia to Reduce Infarct Size

Presenter: Bernard J. Gersh, Michel Ovize, David Erlinge

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Presenter: Thomas F. Luscher, David Erlinge

October 31, 2017

Presentation TCT 2017

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

Presenter: Michael S. Lee, Dirk Sibbing, David Erlinge

October 30, 2017

Presentation TCT 2017

Case #8: Unexpected Stent Failure Visualized by OCT (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Evelyn S. Regar

October 30, 2017

Presentation TCT 2017

Case #7: PCI Induced Intramural Hematoma Visualized by IVUS (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Itshac Itsik Ben-dor

October 30, 2017

Presentation TCT 2017

Case #6: Progression of Vulnerable Plaque by NIRS-IVUS: Should I Have Treated It? (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Ryan D. Madder

October 30, 2017

Presentation TCT 2017

Case #5: An Interesting Spontaneous Coronary Dissection Visualized by OCT (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Jacqueline Saw

October 30, 2017

Presentation TCT 2017

Case #4: OCT Changed My Strategy of Calcified Lesion Stenting (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Jonathan M. Hill

October 30, 2017

Presentation TCT 2017

Case #3: IVUS Changed My Strategy of Left Main Stenting (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Ioannis Iakovou

October 30, 2017

Presentation TCT 2017

Case #2: Stent Sizing, Lesion Length Determination and Optimization by OCT (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Ulf Landmesser

October 30, 2017

Presentation TCT 2017

Case #1: Stent Sizing, Lesion Length Determination and Optimization by IVUS (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Azeem Latib

October 30, 2017

Presentation ESC 2017

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Presenter: David Erlinge

August 27, 2017

Advertisement

Novel Invasive Diagnostics II: NIRS-Based

Prospects for Hypothermia to Reduce Infarct Size

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Parenteral Therapy in STEMI: Does VALIDATE Change the Equation?

Case #8: Unexpected Stent Failure Visualized by OCT (With Discussion)

Case #7: PCI Induced Intramural Hematoma Visualized by IVUS (With Discussion)

Case #6: Progression of Vulnerable Plaque by NIRS-IVUS: Should I Have Treated It? (With Discussion)

Case #5: An Interesting Spontaneous Coronary Dissection Visualized by OCT (With Discussion)

Case #4: OCT Changed My Strategy of Calcified Lesion Stenting (With Discussion)

Case #3: IVUS Changed My Strategy of Left Main Stenting (With Discussion)

Case #2: Stent Sizing, Lesion Length Determination and Optimization by OCT (With Discussion)

Case #1: Stent Sizing, Lesion Length Determination and Optimization by IVUS (With Discussion)

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content